Activated protein C: do more survive?
Macias
William L
WL
D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use; D017277:Drug Approval; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D011486:Protein C / Q000009:adverse effects / Q000187:drug effects* / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy; D012720:Severity of Illness Index; D015996:Survival Rate; D014481:United States
D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated